12:00 AM
Nov 08, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Human Factor VIII and Factor IX clotting proteins regulatory update

PHAR received U.S. Patent No. 5,919,913 for the purification of human lactoferrin from milk. PHAR is developing lactoferrin as a heparin neutralizer following heart surgery, and as an anti-microbial.

PHAR also...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >